Deb Hussain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deb hussain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deb Hussain Today - Breaking & Trending Today

Investegate |Acacia Pharma Group plc Announcements | Acacia Pharma Group plc: Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US

™ (remimazolam injection)
US commercial rights to BYFAVO were in-licensed from Cosmo Pharmaceuticals NV (“Cosmo”) in January 2020 and it was approved in July 2020 for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less which make up around 40m procedures a year in the US, including 25m gastro-intestinal procedures
3 for an estimated >$1.5 billion annual total addressable market
4.
References
1. Calculations based on available procedural data, applied Compound Annual Growth Rate and quantitative market research responses as follows: National Hospital Discharge Survey, 2006; National Survey of Ambulatory Surgery, 2006 (as revised in 2009); Source Healthcare; NCHS 2005; Life Science Strategy Group, LLC Market Research; Apfel et al.,2004. ....

United Kingdom , United States , Talmage Egan , Irina Koffler , Frazer Hall , Mike Bolinder , Gary Gemignani , Richard Dutton , Deb Hussain , Chris Van Raemdonck , University Of Utah , International Media , Link Group For Cosmo Technologies , Department Of Anesthesiology , National Hospital Discharge , Acacia Pharma Group , Data Research , Quantitative Market Research , Baylor Scott White Health , Life Science Strategy Group , National Survey Of Ambulatory Surgery , Market Research , American Society Of Anesthesiologists , Cosmo Pharmaceuticals Nv , Paion United Kingdom , Significant Continued Progress ,

Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US

Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Talmage Egan , Irina Koffler , Frazer Hall , Mike Bolinder , Gary Gemignani , Richard Dutton , Deb Hussain , Chris Van Raemdonck , University Of Utah , International Media , Link Group For Cosmo Technologies , Department Of Anesthesiology , National Hospital Discharge , Acacia Pharma Group , Data Research , Quantitative Market Research , Baylor Scott White Health , Life Science Strategy Group , National Survey Of Ambulatory Surgery , Market Research , American Society Of Anesthesiologists , Cosmo Pharmaceuticals Nv , Paion United Kingdom , Market Abuse Regulation ,

Acacia Pharma Appoints Debra Hussain as Chief Commercial

Acacia
Pharma” or the
Company”) (EURONEXT: ACPH), a commercial-stage biopharmaceutical company focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy, announces the appointment of Debra (Deb) Hussain as Chief Commercial Officer.
“We continue to achieve very strong early commercial success as we execute the launch strategy for BARHEMSYS® and BYFAVO™ in the US and are delighted to welcome Deb to our high-performing team,”
said Mike Bolinder, Chief Executive Officer at Acacia Pharma. “I am so very pleased that we have been able to attract someone of her caliber and experience to join our executive team to fill the role I vacated almost two years ago when I assumed my current role as CEO. Deb brings exceptional commercial experience that we believe will complement our current activities, improve our organizational capabilities, ....

United States , United Kingdom , Mike Bolinder , Debra Deb Hussain , Debra Hussain , Eli Lilly , Deb Hussain , University Of Wisconsin , Company Lilly , Memphis State University , Acacia Pharma Group , Paion United Kingdom , Pharma Appoints Debra Hussain , Chief Commercial , Chief Executive Officer , Acacia Pharma , Riley Hospital , Memphis State , Paion United Kingdom Limited , Euronext Brussels , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , எலி லில்லி , பல்கலைக்கழகம் ஆஃப் விஸ்கான்சின் , நிறுவனம் லில்லி , மெம்பிஸ் நிலை பல்கலைக்கழகம் ,